Johannes Wesling Klinikum Minden
Minden, Germany
University hospital in Minden, North Rhine-Westphalia
Hans-Nolte-Straße 1, 32429 Minden
About Johannes Wesling Klinikum Minden
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
10
Celgene
4
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
4
University Hospital Tuebingen
4
Biotronik SE & Co. KG
3
European Organisation for Research and Treatment of Cancer - EORTC
3
Pfizer
3
University Hospital Schleswig-Holstein
3
Universitätsklinikum Hamburg-Eppendorf
3
AGO Research GmbH
2
Clinical Trials at Johannes Wesling Klinikum Minden
During the past decade, Johannes Wesling Klinikum Minden conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 13 clinical trials were completed, i.e. on
average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
2003-01-01
2011-06-01
Terminated
93
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
2003-10-01
2010-09-01
Completed
49
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Johannes Wesling Klinikum Minden" #1 sponsor was "University of Ulm" with 10 trials, followed by "Celgene" with 4 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored and "University Hospital Tuebingen"
with 4 trials sponsored. Other sponsors include 60 different institutions and
companies that sponsored additional 54 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Johannes Wesling Klinikum Minden"
#1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Hannover Medical School" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 73 different institutions and companies that were
collaborators in the rest 82 trials.
Clinical Trials Conditions at Johannes Wesling Klinikum Minden
According to Clinical.Site data, the most researched conditions in "Johannes Wesling Klinikum Minden" are
"Lymphoma" (8 trials), "Primary Myelofibrosis" (6 trials), "Acute Myeloid Leukemia (AML)" (5 trials), "Leukemia" (5 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "Johannes Wesling Klinikum Minden" in a lesser frequency.
Clinical Trials Intervention Types at Johannes Wesling Klinikum Minden
Most popular intervention types in "Johannes Wesling Klinikum Minden" are "Drug" (70 trials), "Biological" (17 trials), "Radiation" (14 trials), "Procedure" (12 trials) and "Device" (7 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (11 trials), "doxorubicin hydrochloride" (10 trials), "radiation therapy" (10 trials), "vincristine sulfate" (9 trials) and "Placebo" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Johannes Wesling Klinikum Minden
The vast majority of trials in "Johannes Wesling Klinikum Minden" are
85 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Johannes Wesling Klinikum Minden
Currently, there are NaN active trials in "Johannes Wesling Klinikum Minden".
undefined are not yet recruiting,
15 are recruiting,
18 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 43 completed trials in Johannes Wesling Klinikum Minden,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Johannes Wesling Klinikum Minden, 2 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 44 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 11 trials that are defined as “Not Applicable".